Published in Expert Rev Vaccines on December 01, 2009
Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnol (2011) 0.89
Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin. Vaccine (2010) 0.89
Current and emerging cell culture manufacturing technologies for influenza vaccines. Biomed Res Int (2015) 0.89
Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles. PLoS One (2013) 0.89
Heterogeneity of the MDCK cell line and its applicability for influenza virus research. PLoS One (2013) 0.88
Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection. Nat Commun (2015) 0.86
Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. PLoS One (2011) 0.86
Enhanced production of human influenza virus in PBS-12SF cells with a reduced interferon response. Hum Vaccin Immunother (2015) 0.83
Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells. BMC Biotechnol (2012) 0.83
Comparison of different cell substrates on the measurement of human influenza virus neutralizing antibodies. PLoS One (2012) 0.82
Effect of influenza virus infection on key metabolic enzyme activities in MDCK cells. BMC Proc (2011) 0.80
Advances in cell culture: anchorage dependence. Philos Trans R Soc Lond B Biol Sci (2015) 0.79
Vaccination against influenza with recombinant hemagglutinin expressed by Schizochytrium sp. confers protective immunity. PLoS One (2013) 0.79
Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells. BMC Biotechnol (2011) 0.78
Failure-to-thrive syndrome associated with tumor formation by Madin-Darby canine kidney cells in newborn nude mice. Comp Med (2013) 0.76
Cell culture-based influenza vaccines: A necessary and indispensable investment for the future. Hum Vaccin Immunother (2015) 0.76
Establishment of a new quality control and vaccine safety test for influenza vaccines and adjuvants using gene expression profiling. PLoS One (2015) 0.75
Reverse Genetics Approaches for the Development of Influenza Vaccines. Int J Mol Sci (2016) 0.75
Establishment of MDCK Stable Cell Lines Expressing TMPRSS2 and MSPL and Their Applications in Propagating Influenza Vaccine Viruses in Absence of Exogenous Trypsin. Biotechnol Res Int (2015) 0.75
Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines. PLoS One (2015) 0.75
Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol Bioeng (2005) 1.55
Metabolic effects of influenza virus infection in cultured animal cells: Intra- and extracellular metabolite profiling. BMC Syst Biol (2010) 1.36
Simultaneous extraction of several metabolites of energy metabolism and related substances in mammalian cells: optimization using experimental design. Anal Biochem (2007) 1.13
Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine (2009) 1.04
Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines. Proteomics (2009) 1.04
PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia. Blood (2013) 1.03
Growth behavior of number distributed adherent MDCK cells for optimization in microcarrier cultures. Biotechnol Prog (2009) 1.03
Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis. J Virol (2012) 1.00
Substitution of glutamine by pyruvate to reduce ammonia formation and growth inhibition of mammalian cells. Biotechnol Prog (2005) 0.97
High yields of influenza A virus in Madin-Darby canine kidney cells are promoted by an insufficient interferon-induced antiviral state. J Gen Virol (2010) 0.96
Metagenome and metaproteome analyses of microbial communities in mesophilic biogas-producing anaerobic batch fermentations indicate concerted plant carbohydrate degradation. Syst Appl Microbiol (2013) 0.95
Neuraminidase activity assays for monitoring MDCK cell culture derived influenza virus. J Virol Methods (2004) 0.95
Adaption of a fragment analysis technique to an automated high-throughput multicapillary electrophoresis device for the precise qualitative and quantitative characterization of microbial communities. Electrophoresis (2002) 0.94
Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals (2008) 0.94
Real-time RT-qPCR assay for the analysis of human influenza A virus transcription and replication dynamics. J Virol Methods (2010) 0.93
Characterization of a three bacteria mixed culture in a chemostat: evaluation and application of a quantitative terminal-restriction fragment length polymorphism (T-RFLP) analysis for absolute and species specific cell enumeration. Biotechnol Bioeng (2007) 0.92
The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation. J Proteome Res (2015) 0.89
Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals. PLoS Comput Biol (2013) 0.89
Searching for a needle in a stack of needles: challenges in metaproteomics data analysis. Mol Biosyst (2013) 0.89
Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles. PLoS One (2013) 0.89
Comparison of metabolic flux distributions for MDCK cell growth in glutamine- and pyruvate-containing media. Biotechnol Prog (2008) 0.88
Metabolic flux model for an anchorage-dependent MDCK cell line: characteristic growth phases and minimum substrate consumption flux distribution. Biotechnol Bioeng (2008) 0.88
N-glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N-glycosylation during vaccine production. Electrophoresis (2008) 0.88
High-performance anion-exchange chromatography using on-line electrolytic eluent generation for the determination of more than 25 intermediates from energy metabolism of mammalian cells in culture. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.86
A flow cytometric method for viability assessment of Staphylococcus aureus and Burkholderia cepacia in mixed culture. Cytometry A (2012) 0.86
Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production. Appl Microbiol Biotechnol (2014) 0.86
Metaproteome analysis to determine the metabolically active part of a thermophilic microbial community producing biogas from agricultural biomass. Can J Microbiol (2012) 0.85
Impact of host cell line adaptation on quasispecies composition and glycosylation of influenza A virus hemagglutinin. PLoS One (2011) 0.85
Toward animal cell culture-based influenza vaccine design: viral hemagglutinin N-glycosylation markedly impacts immunogenicity. J Immunol (2012) 0.85
Metaproteome analysis of sewage sludge from membrane bioreactors. Proteomics (2011) 0.84
Downstream processing of cell culture-derived virus particles. Expert Rev Vaccines (2011) 0.84
Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: a proteomic approach. J Proteomics (2010) 0.84
Effects of a recombinant gene expression on ColE1-like plasmid segregation in Escherichia coli. BMC Biotechnol (2011) 0.84
MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Appl Microbiol Biotechnol (2010) 0.84
Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng (2007) 0.84
Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response. Appl Microbiol Biotechnol (2011) 0.84
Experimental characterization of flow conditions in 2- and 20-L bioreactors with wave-induced motion. Biotechnol Prog (2011) 0.83
Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnol Bioeng (2007) 0.83
Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells. BMC Biotechnol (2012) 0.83
Proteome analysis of virus-host cell interaction: rabies virus replication in Vero cells in two different media. Appl Microbiol Biotechnol (2013) 0.81
Amino acid analysis in mammalian cell culture media containing serum and high glucose concentrations by anion exchange chromatography and integrated pulsed amperometric detection. Anal Biochem (2004) 0.81
Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production. BMC Biotechnol (2008) 0.80
glyXalign: high-throughput migration time alignment preprocessing of electrophoretic data retrieved via multiplexed capillary gel electrophoresis with laser-induced fluorescence detection-based glycoprofiling. Electrophoresis (2013) 0.79
Characterization of flow conditions in 2 L and 20 L wave bioreactors using computational fluid dynamics. Biotechnol Prog (2010) 0.79
Development of a high-throughput glycoanalysis method for the characterization of oligosaccharides in human milk utilizing multiplexed capillary gel electrophoresis with laser-induced fluorescence detection. Electrophoresis (2013) 0.79
Efficient influenza B virus propagation due to deficient interferon-induced antiviral activity in MDCK cells. Vaccine (2011) 0.79
Community shifts in a well-operating agricultural biogas plant: how process variations are handled by the microbiome. Appl Microbiol Biotechnol (2015) 0.79
Proteomic tracking and analysis of a bacterial mixed culture. Proteomics (2012) 0.79
Coexistence in the chemostat as a result of metabolic by-products. J Math Biol (2006) 0.78
Identification of growth phases and influencing factors in cultivations with AGE1.HN cells using set-based methods. PLoS One (2013) 0.78
Segregated mathematical model for growth of anchorage-dependent MDCK cells in microcarrier culture. Biotechnol Prog (2008) 0.78
Flow cytometric viability assessment of lactic acid bacteria starter cultures produced by fluidized bed drying. Appl Microbiol Biotechnol (2014) 0.78
Species-specific viability analysis of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus in mixed culture by flow cytometry. BMC Microbiol (2014) 0.78
Atmospheric pressure free liquid infrared MALDI mass spectrometry: toward a combined ESI/ MALDI-liquid chromatography interface. Anal Chem (2009) 0.78
Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent. J Virol Methods (2008) 0.77
Bioreactor concepts for cell culture-based viral vaccine production. Expert Rev Vaccines (2015) 0.77
CAP, a new human suspension cell line for influenza virus production. Appl Microbiol Biotechnol (2012) 0.77
A novel concept combining experimental and mathematical analysis for the identification of unknown interspecies effects in a mixed culture. Biotechnol Bioeng (2011) 0.77
Interspecies effects in a ceftazidime-treated mixed culture of Pseudomonas aeruginosa, Burkholderia cepacia and Staphylococcus aureus: analysis at the single-species level. J Antimicrob Chemother (2010) 0.77
Impact of cultivation conditions on N-glycosylation of influenza virus a hemagglutinin produced in MDCK cell culture. Biotechnol Bioeng (2013) 0.77
The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis. BMC Biotechnol (2014) 0.76
How can measurement, monitoring, modeling and control advance cell culture in industrial biotechnology? Biotechnol J (2012) 0.76
Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography. Biotechnol Bioeng (2010) 0.76
N-Glycosylation Fingerprinting of Viral Glycoproteins by xCGE-LIF. Methods Mol Biol (2015) 0.76
Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers. Biotechnol Bioeng (2010) 0.75
Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography. J Virol Methods (2009) 0.75
Profiling of external metabolites during production of hantavirus nucleocapsid protein with recombinant Saccharomyces cerevisiae. Biotechnol Lett (2007) 0.75
MPA Portable: a Stand-alone Software Package for Analyzing Metaproteome Samples on the Go. Anal Chem (2017) 0.75
Concentration polarization and nonequilibrium electroosmotic slip in dense multiparticle systems. Langmuir (2007) 0.75
Editorial: Can modern vaccine technology pursue the success of traditional vaccine manufacturing? Biotechnol J (2015) 0.75
Vaccine production: upstream processing with adherent or suspension cell lines. Methods Mol Biol (2014) 0.75
Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles. Biotechnol Bioeng (2009) 0.75
Downstream processing of MDCK cell-derived equine influenza virus. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.75
Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses. J Biotechnol (2007) 0.75
Distributed modeling of human influenza A virus-host cell interactions during vaccine production. Biotechnol Bioeng (2013) 0.75
Size-exclusion chromatography as a linear transfer system: purification of human influenza virus as an example. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.75
Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine (2006) 0.75